Liyana Ahmad Zamri1*, Nur Azlin Zainal Abidin1, Farah Huda Mohkiar2, You Zhuan Tan2, Fazliana Mansor1, Poh Yue Tsen2, Shu Yu Lim3,4,5, Gee Tikfu3,4,5
1. Endocrine & Metabolic Unit, Nutrition, Metabolism & Cardiovascular Research Centre, Institute for Medical Research, National Institute of Health, Ministry of Health Malaysia, 40170 Shah Alam, Selangor, Malaysia
2. Cardiovascular Unit, Nutrition, Metabolism & Cardiovascular Research Centre, Institute for Medical Research, National Institute of Health, Ministry of Health Malaysia, 40170 Shah Alam, Selangor, Malaysia
3. Sunway Medical Centre, Bandar Sunway, 47500 Petaling Jaya, Selangor
4. iHeal Medical Centre, Mid Valley City, 59200 Kuala Lumpur, Malaysia
5. Sunway Velocity Medical Centre, Sunway Velocity, 55100 Lumpur, Malaysia
*Corresponding author: Liyana Ahmad Zamri.
ABSTRACT
INTRODUCTION: Obesity-related dyslipidaemia increases cardiovascular risk. Despite the known benefits of bariatric surgery on metabolic health, its distinct effects on lipid profiles across different glycaemic categories are not well understood.
OBJECTIVE: This study aimed to evaluate 12-month lipid profile trajectories in obese individuals undergoing bariatric surgery, stratified by glycaemic status.
MATERIALS & METHODS: Forty-one obese participants undergoing bariatric surgery (sleeve gastrectomy, Roux-en-Y, or mini-gastric bypass) at medical centres in the Klang Valley were assessed at baseline, 6, and 12 months. Participants were stratified as non-diabetic (ND, n=17), prediabetic (PDM, n=12), and diabetic (DM, n=12) based on baseline HbA1c levels, following the current national guidelines. Lipid parameters were analysed using generalised estimating equation (GEE), adjusted for age, sex, time, glycaemic status group, and baseline lipid levels.
RESULTS: Participants were mostly female (63.4%) and Malay (68.3%), with a mean age of 38.0 ± 7.3 years and a mean BMI of 40.1 ± 8.2 kg/m². Overall, the prevalence of dyslipidaemia decreased from 88% at baseline to 39% at 12 months, indicating 56% resolution. Significant within-group improvements were observed in HDL-C, triglycerides (TG), and TC:HDL-C ratio across all glycaemic categories. HDL-C increased significantly between 6 and 12 months in all groups (DM: +0.20, PDM: +0.19, ND: +0.29 mmol/L), while TG declined substantially in the first 6 months in DM and PDM groups (−0.43 mmol/L and −0.36 mmol/L, respectively). TC:HDL-C ratio improved significantly in ND and DM groups, particularly from 6 to 12 months. No significant time-by-group interaction was found, indicating that lipid profile trajectories over 12 months were similar across glycaemic groups.
CONCLUSION: Bariatric surgery significantly improved lipid profiles and cardiovascular risk markers over 12 months, regardless of baseline glycaemic status. These findings support its role in mitigating cardiometabolic risk across the spectrum of obesity, highlighting its value as a metabolic intervention that extends beyond weight loss.
KEYWORDS: Obesity, Diabetes, Lipid Profiles, Bariatric Surgery, Cardiovascular Risk


